Can Low LDL Be Due to Inflammation?
No, inflammation does not cause low LDL cholesterol—in fact, the relationship is the opposite: elevated LDL cholesterol shows no causal association with systemic inflammation, while low LDL levels are typically genetic or medication-induced, not inflammation-driven. 1
The Evidence Against Inflammation Causing Low LDL
The most robust evidence from Mendelian randomization studies demonstrates that:
A 1-mmol/L (39 mg/dL) higher LDL cholesterol level was associated observationally with only a 7% higher C-reactive protein level, with no causal association found. 1 This directly contradicts the hypothesis that inflammation lowers LDL.
Patients with familial hypercholesterolemia (both heterozygous and homozygous forms) who have genetically elevated LDL cholesterol showed either no difference or only slightly higher C-reactive protein levels compared to controls. 1 If inflammation lowered LDL, these patients with extremely high LDL (up to 650 mg/dL) would be expected to have very low inflammatory markers—but they don't.
The simplest explanation is that elevated LDL cholesterol does not cause low-grade inflammation, whereas elevated triglyceride-rich lipoproteins do. 1
What Actually Causes Low LDL Cholesterol
Genetic Conditions
Low LDL cholesterol is primarily caused by genetic mutations affecting lipoprotein metabolism:
PCSK9 loss-of-function mutations can result in LDL-C as low as 14 mg/dL, with affected individuals remaining healthy, fertile, and without neurocognitive impairment. 1
Familial hypobetalipoproteinemia results in LDL-C levels of 20-50 mg/dL, with homozygous carriers having levels as low as 27 mg/dL. 1
Abetalipoproteinemia causes undetectable LDL-C levels due to mutations in microsomal triglyceride transfer protein. 1
These genetic conditions demonstrate that very low LDL-C (even <30 mg/dL) is not associated with increased diabetes mellitus or hemorrhagic stroke. 1
Pharmacologic Interventions
- Statin therapy, PCSK9 inhibitors, ezetimibe, and bempedoic acid all lower LDL-C through direct mechanisms unrelated to inflammation. 2
The Inflammation-Lipid Relationship: What Actually Happens
Inflammation Affects LDL Quality, Not Quantity
When inflammation is present, the changes affect LDL particle characteristics rather than absolute LDL-C levels:
Chronic inflammatory diseases (rheumatoid arthritis, inflammatory bowel disease, ankylosing spondylitis, psoriasis) are associated with significantly higher small-dense LDL content within the LDL cholesterol fraction (33-42% vs. controls), despite often having lower total LDL-C levels—the "LDL paradox." 3
Endothelial lipase is upregulated during inflammation, which increases LDL oxidation and atherogenesis, but this affects LDL modification, not LDL-C concentration. 1
LDL particles become more susceptible to lipid peroxidation during inflammation, making them more atherogenic despite potentially lower absolute levels. 1
Systemic Inflammation and Lipid Changes
The documented effects of inflammation on lipids include:
Systemic inflammation results in elevated triglycerides and reduced HDL-C in most mammalian species. 4
Most reports indicate that systemic inflammation, as observed during sepsis or high-dose experimental endotoxemia, actually lowers total and LDL-C in humans. 4
Low-grade intestinal inflammation specifically may be associated with increased serum LDL-C levels through downregulation of trans-intestinal cholesterol efflux (TICE), but this represents a specialized scenario, not a general principle. 4
Clinical Implications and Pitfalls
Common Misinterpretations to Avoid
Do not assume that low LDL-C in a patient with inflammatory disease is caused by the inflammation itself—more likely explanations include medication effects, malnutrition, liver disease, or genetic factors.
The "LDL paradox" in chronic inflammatory diseases refers to increased cardiovascular risk despite lower LDL-C levels, explained by increased small-dense LDL particles and oxidized LDL, not by inflammation lowering LDL-C. 3
LDL-triglyceride content (not LDL-C concentration) is associated with systemic inflammation markers (CRP, IL-6, ICAM-1, VCAM-1) and better reflects atherogenic potential than LDL-C alone. 5
When to Investigate Low LDL-C
Evaluate for:
- Genetic hypobetalipoproteinemia syndromes if LDL-C is persistently <50 mg/dL without medication 1
- Malabsorption, liver disease, hyperthyroidism, or malnutrition (general medical knowledge)
- Medication effects from statins, PCSK9 inhibitors, or other lipid-lowering agents 2
The Separate Pathways Concept
IL-6 mediated inflammation and LDL cholesterol are two separate causes of atherosclerotic cardiovascular disease that operate in parallel, not in a cause-effect relationship with each other. 6 This fundamental understanding prevents misattribution of low LDL-C to inflammatory processes.